Breaking News, Collaborations & Alliances

Janssen R&D, MMRF In Personalized Medicine Pact

To discover and develop new approaches to treating multiple myeloma

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Janssen R&D, LLC has joined the Multiple Myeloma Research Foundation (MMRF) pre-competitive consortium (PCC) to discover and develop new approaches to treating multiple myeloma through the organization’s Personalized Medicine Initiative (PMI). This initiative includes CoMMpass Study (Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile) that collects comprehensive clinical information and molecular profiles of 1,000 newly diagnosed patients for a minimum o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters